Home 2015
Archives
FDA Approves Imlygic for Melanoma
Injectable drug designed to rupture and kill cancer cells
CDC: E-Cigarette Use Highest Among 18- to 24-Year-Olds
Almost 4 percent of all adult Americans use them, new survey shows
FDA Requires New Warning on Two Hepatitis C Drugs
Cautionary label will be added to Viekira Pak and Technivie, agency says
FDA Approves Onivyde for Metastatic Pancreatic Cancer
To be used in combination with fluorouracil/leucovorin for advanced disease
FDA Approves Yondelis for Soft-Tissue Sarcoma
Drug sanctioned for liposarcoma or leiomyosarcoma
FDA Approves Coagadex for Rare Clotting Disorder
First coagulation therapy sanctioned for Factor X deficiency
FDA Approves Praxbind to Reverse Pradaxa’s Effect
Praxbind cleared for emergency use with Pradaxa when bleeding can't be controlled
CDC: Prescribing Practices Key to Curbing Rx Abuse
Small number of doctors write most opioid prescriptions, study finds
Americans Spend More on Health Care, but Fare Worse
Comparison with 12 industrialized nations shows more money spent, but life expectancy is lowest
Ebola Survivor’s Case Points to Delayed Complications
Health officials say the risk to the general public remains low
